Short-term ECG recordings for heart rate assessment in patients with chronic atrial fibrillation

Archives of Medical Science

Volumn 10, Issue 4, 2014, Pages 676-683

  Chudzik, Michal ^a   Cygankiewicz, Iwona ^a   Klimczak, Artur ^a   Lewek, Joanna ^a   Bartczak, Karol ^a   Wranicz, Jerzy K ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Atrial fibrillation; Rate irregularity; Ventricular rate control

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL PRACTICE; COMORBIDITY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DISEASE DURATION; ELECTROCARDIOGRAM; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HOLTER MONITOR; HOLTER MONITORING; HUMAN; HYPERTENSION; LONG TERM CARE; MALE; NEW YORK HEART ASSOCIATION CLASS; PATIENT MONITORING; PROGNOSIS; VALVULAR HEART DISEASE; VERY ELDERLY;

EID: 84907462629     PISSN: 17341922     EISSN: 18969151     Source Type: Journal    
DOI: 10.5114/aoms.2014.44859     Document Type: Article

References (30)

1. Luderitz B, Jung W. Quality of life in patients with atrial fibrillation. Arch Intern Med 2000; 160: 1749-57. (Pubitemid 30418811)
2. Thrall G, Lane D, Carroll D, Lip GY. Quality of life in patients with atrial fibrillation: a systematic review. Am J Med 2006; 119: 448.e1-19.
3. Melenowsky V, Hay I, Fetics BJ. Functional impact of rate irregularity in patients with heart failure and atrial fibrillation receiving cardiac resynchronization therapy. Eur Heart J 2005; 26: 705-11. (Pubitemid 40516883)
4. Dandamudi G, Rampurwala AY, Mahenthiran J, Miller JM, Das MK. Persistent left ventricular dilatation in tachycardia-induced cardiomyopathy patients after appropriate treatment and normalization of ejection fraction. Heart Rhythm 2008; 8: 1111-4.
5. Gopinathannair R, Sullivan R, Olshansky B. Tachycardia-mediated cardiomyopathy: recognition and management. Curr Heart Fail Rep 2009; 6: 257-64.
6. Jeong YH, Choi KJ, Song JM, et al. Diagnostic approach and treatment strategy in tachycardia-induced cardiomyopathy. Clin Cardiol 2008; 31: 172-8.
7. Hohnloser SH, Kuck KH, Lilienthal J; the PIAF investigators. Rhythm or rate control in atrial fibrillation - Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial. Lancet 2000; 356: 1789-94.
8. Carlsson J, Miketic S, Windeler J, et al.; the STAF investigators. Randomized trial of rate-control versus rhytm control in persistent atrial fibrillation. The strategies of treatment on atrial fibrillation (STAF) study. Am Coll Cardiol 2003; 41: 1690-1.
9. Galder IC, Hagens VE, Bosker HA, et al.; the Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002; 347: 1834-40. (Pubitemid 35417774)
10. Wyse DG, Waldo AL, DiMarco JP, et al.; the the AFFIRM investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 347: 1825-33. (Pubitemid 35417773)
11. Olshansky B, Rosenfeld LE, Warner AL, et al. The atriall fibrillation follow up investigation of rhythm management (AFFIRM) study. Approaches to control rate in atrial fibrillation. J Am Coll Cardiol 2004; 43: 1201-8. (Pubitemid 38452597)
12. Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 2006; 8: 651-745. (Pubitemid 44472247)
13. McBride D, Mattenklotz AM, Willich SN, Brüggenjürgen B. The costs of care in atrial fibrillation and the effect of treatment modalities in Germany. Value Health 2009; 12: 293-301.
14. Naccarelli GV, Johnston SS, Lin J, Patel PP, Schulman KL. Cost burden of cardiovascular hospitalization and mortality in ATHENA-like patients with atrial fibrillation/atrial flutter in the United States. Clin Cardiol 2010; 33: 270-9.
15. Greenhut SE, Fraser J, Steinhaus B, Feld G, Hughes W. Optimized standby rate reduces the ventricular rate variability in pacemaker patients with atrial fibrillation. Pacing Clin Electrophysiol 1996; 19: 1780-5. (Pubitemid 26398450)
16. Stein KM, Borer JS, Hochreiter C, Devereux RB, Kligfield P. Variability of the ventricular response in atrial fibrillation and prognosis in chronic nonischemic mitral regurgitation. Am J Cardiol 1994; 74: 906-1111.
17. Clark DM, Plumb VJ, Epstein AE, Kay GN. Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. J Am Coll Cardiol 1997; 30: 1039-45. (Pubitemid 27435898)
18. Naito M, David D, Michelson EL. The hemodynamic consequence of cardiac arrhythmias: evaluation of the relative roles of abnormal atrioventricular sequencing, irregularity of ventricular rhythm and atrial fibrillation in a canine model. Am Heart J 1983; 106: 284-91. (Pubitemid 13028230)
19. Okcun B, Yigit Z, Yildiz A. What should be the primary treatment in atrial fibrillation: ventricular rate control or sinus rhythm control with long-term anticoagulation? J Int Med Res 2009; 37: 464-71.
20. Climent AM, Guillem MS, Husser D, Castells F, Millet J, Bollmann A. Role of the atrial rate as a factor modulating ventricular response during atrial fibrillation. Pacing Clin Electrophysiol 2010; 15: 1-8.
21. Hollerbach AD, Sneed NV. Accuracy of radial pulse assessment by length of counting interval. Heart Lung 1990; 19: 258-64. (Pubitemid 20180551)
22. Sneed NV, Hollerbach AD. Accuracy of heart rate assessment in atrial fibrillation. Heart Lung 1992; 21: 427-33.
23. Watt JH, Donner AP, McKinney CM, Klein GJ. Atrial fibrillation: minimal sampling interval to estimate average rate. J Electrocardiol 1984; 17: 153-6. (Pubitemid 14142612)
24. Atwood JE, Myers J, Sandhu S, et al. Optimal sampling interval to estimate heart rate at rest and during exercise in atrial fibrillation. Am J Cardiol 1989; 63: 45-8. (Pubitemid 19018938)
25. Wasmund SL, Pai RK, Freedman RA, et al. Modulation of the sinus rate during ventricular fibrillation. J Cardiovasc Electrophysiol 2009; 20: 187-92.
26. Chou CC, Chen PS. New concepts in atrial fibrillation: mechanism and remodeling. Med Clin North Am 2008; 92: 53-63.
27. Ueshima K, Myers J, Ribis PM, et al. Exercise capacity and prognosis in patients with chronic atrial fibrillation. Cardiology 1995; 86: 108-13.
28. Daoud EG, Weiss R, Bahu M. Effect of an irregular ventricular rhythm on cardiac output. Am J Cardiol 1996; 78: 1433-6. (Pubitemid 126657243)
29. Tse HF, Wong KK, Siu CW, et al. Impacts of ventricular rate regularization pacing at right ventricular apical vs. septal sites on left ventricular function and exercise capacity in patients with permanent atrial fibrillation. Europace 2009; 11: 594-600.
30. Chudzik M, Wranicz JK, Cygankiewicz I, Klimczak A, Goch JK. Is mean heart rate a reliable predictor in the pharmacotherapy of patients with atrial fibrillation? Folia Cardiol 2006; 13: 473-9. (Pubitemid 44614387)